Eric A. Ross
Department of Cancer Research
Fox Chase Cancer Center
United States of America
Biography
Eric A. Ross, Educational Background: PhD, Statistics, Temple University, 1996 ScM, Biostatistics, Bloomberg School of Public Health, The Johns Hopkins University, 1984 BA, Biological Sciences, University of Delaware, 1980 Memberships : American Statistical Association, member International Biometrics Society, member American Medical Informatics Association, member Society for Clinical Trials, member
Research Interest
Development of new randomized phase II clinical trial designs. Application of state of the art statistical approaches to rigorously extend the quantitative interpretation of data. Large-scale data integration, and the development and application of web-based technologies to enable remote data collection/presentation, health education and new interventions.
Publications
-
Schilder, R. J., Pathak, H. B., Lokshin, A. E., Holloway, R. W., Alvarez, R. D., Aghajanian, C., ... & Godwin, A. K. (2009). Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecologic oncology, 113(1), 21-27.
-
Ariazi, E. A., Cunliffe, H. E., Lewis-Wambi, J. S., Slifker, M. J., Willis, A. L., Ramos, P., ... & Nicolas, E. (2011). Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proceedings of the National Academy of Sciences, 108(47), 18879-18886.
-
Bleicher, R. J., Ruth, K., Sigurdson, E. R., Ross, E., Wong, Y. N., Patel, S. A., ... & Egleston, B. L. (2012). Preoperative delays in the US Medicare population with breast cancer. Journal of Clinical Oncology, 30(36), 4485-4492.
-
Min, H., Ohira, R., Collins, M. A., Bondy, J., Avis, N. E., Tchuvatkina, O., ... & Cooper, M. (2013). Sharing behavioral data through a grid infrastructure using data standards. Journal of the American Medical Informatics Association, 21(4), 642-649.
-
Plimack, E. R., Hoffman-Censits, J. H., Viterbo, R., Trabulsi, E. J., Ross, E. A., Greenberg, R. E., ... & Kutikov, A. (2014). Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. Journal of Clinical Oncology, 32(18), 1895-1901.
-
Weinberg, D. S., Myers, R. E., Keenan, E., Ruth, K., Sifri, R., Ziring, B., ... & Manne, S. L. (2014). Genetic and Environmental Risk Assessment and Colorectal Cancer Screening in an Average-Risk PopulationA Randomized TrialRisk Assessment and Colorectal Cancer Screening. Annals of internal medicine, 161(8), 537-545.
-
Plimack, E. R., Dunbrack, R. L., Brennan, T. A., Andrake, M. D., Zhou, Y., Serebriiskii, I. G., ... & Hoffman-Censits, J. (2015). Defects in DNA repair genes predict response to neoadjuvant cisplatin-based chemotherapy in muscle-invasive bladder cancer. European urology, 68(6), 959-967.
